Properdin Modulation

Properdin Modulation is a pharmacological intervention strategy that selectively enhances or inhibits the functional activity of properdin, a positive regulator of the alternative complement pathway, to attenuate or potentiate complement-mediated immune responses in a targeted manner.

19

Publications

1.3K

Citations

95

Authors

48

Institutions

Publications per year

2017–2026

4

Authors

95

  1. CS
    Cordula Stover

    University of Leicester, United Kingdom

    4 publications · 181 citations

    4

    h-index

  2. RG
    R G Medicus

    Scripps Health, United States

    3 publications · 245 citations

    3

    h-index

  3. HJ
    Hans J. Müller‐Eberhard

    Scripps Health, United States

    3 publications · 245 citations

    3

    h-index

  4. GA
    G.R. Andersen

    Aarhus University, Denmark

    3 publications · 106 citations

    3

    h-index

  5. DP
    Dennis Pedersen

    Aarhus University, Denmark

    3 publications · 106 citations

    3

    h-index

1–5 of 95

Venues

  1. The Journal of Experimental Medicine

    3 publications · 727 citations

    3

    h-index

  2. Molecular Immunology

    2 publications · 85 citations

    2

    h-index

  3. Science

    1 publications · 93 citations

    1

    h-index

  4. Biochemical and Biophysical Research Communications

    BBRC · 1 publications · 58 citations

    1

    h-index

  5. The EMBO Journal

    1 publications · 70 citations

    1

    h-index

1–5